WAYNE, Pennsylvania
,
March 13, 2024
(press release)
–
TekniPlex Healthcare, which utilizes advanced materials science expertise to help deliver better patient outcomes, will emphasize its expertise and intellectual property related to the single-use bioprocessing and the cell and gene therapy markets at INTERPHEX NYC, April 16-18. At its Booth 3837, the company will highlight its portfolio for the burgeoning biologics niche, for which it supplies complementary solutions across the upstream, downstream processing and final fill operations. Solutions include an array of customizable barrier cleanroom films, tubing such as weldable TPE and TPV, silicone and PVC, as well as various compounds for associated molded components. For cell and gene therapy applications, TekniPlex Healthcare is a leader in the production and supply of tubing in a variety of configurations, grades and durometers. Both single- and multi-lumen constructions are available, as are multi-layer versions incorporating complementary materials for performance optimization. For traditional bioprocess applications, TekniPlex Healthcare produces tight-tolerance biopharm-grade constructions comprised of TPE, TPV and silicones. For each of its offerings, the company’s manufacturing prowess boasts extrusion across four continents, and covers all stages of the drug development process, from small batch production through scale-up and commercial quantities. TPE, TPV, silicone and PVC tubing Also at INTERPHEX NYC, TekniPlex Healthcare will tout its coextrusion film capabilities, including newly expanded cleanroom manufacturing capacity for multilayer films suitable for single-use bioprocessing applications. Situated in the company’s Puurs, Belgium facility, the new ISO 7 cleanroom multilayer blown film line joins existing cast coextrusion ISO 7 cleanroom manufacturing capacity suitable for bioprocessing bag film production. The additional film production further expands the company’s capabilities to provide customizable film solutions to bioprocessing bag manufacturers, with a wide range of potential resin combinations helping meet durability needs, as well as extractables and leachables profile requirements. The company’s assets also include a pilot film coextrusion line in its Global Innovation Center in Holland, OH for quick prototyping, helping biopharma-focused companies iterate film options quickly to reduce go to market time and costs. The company also has recently installed cleanroom bag prototyping equipment allowing it to assemble 2-D single-use bioprocessing bags for concept validation and application testing purposes. “As the biologics sector continues its steady growth, so does the need for high-quality materials and components suppliers who can also be innovative solutions partners,’ said Chris Qualters, CEO of TekniPlex Healthcare. “With our expanding capacities and innovative mindset, TekniPlex Healthcare is poised and ready to respond to the evolving needs of the sector, providing value-added solutions that help bring life-changing therapies to market.” About TekniPlex Healthcare TekniPlex Healthcare utilizes advanced materials science expertise and technologies to develop and deliver critical solutions for medical and diagnostic devices, drug delivery systems and healthcare packaging applications. With a global reach, the division’s deep understanding of the greater pharmaceuticals and medical landscape helps it produce exemplary barrier properties for drugs and precision medical devices for interventional and therapeutic procedures. In the medical device niche, TekniPlex Healthcare embodies a comprehensive CDMO partner capable of servicing every stage of the product life cycle, from design and development through component manufacturing and final assembly. Throughout its broad purview, the division’s ever-evolving portfolio helps meet demands for high-leverage medicines and mission-critical healthcare products that benefit care providers and patients. For more information visit www.tekni-plex.com/healthcare.
* All content is copyrighted by Industry Intelligence, or the original respective author or source. You may not recirculate, redistrubte or publish the analysis and presentation included in the service without Industry Intelligence's prior written consent. Please review our terms of use.
